Obsidian Therapeutics
Biotechnology ResearchView the employees at
Obsidian Therapeutics-
Jeff Holderness Director CMC Cell Therapy
-
Nashua, New Hampshire, United States
-
Top 10%
Alfredo Rojas Analytical Scientist at Obsidian Therapeutics-
Marlborough, Massachusetts, United States
-
Rising Star
Eric Gennell Director, Quality Assurance, Obsidian Therapeutics-
Londonderry, New Hampshire, United States
-
Rising Star
Elizabeth (Berry) Reyon Director of Program Management at Obsidian Therapeutics-
Cambridge, Massachusetts, United States
-
Top 5%
Hannah Murphy Senior Research Associate at Obsidian Therapeutics, Inc.-
Cambridge, Massachusetts, United States
-
Rising Star
Overview
Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s programs apply our cytoDriveTM technology in cell and gene therapy products to control expression of proteins for enhanced therapeutic efficacy, including our lead program cytoTIL15 engineered to make TILs more effective for more patients. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need. Located in the heart of Cambridge with a new laboratory facility in Bedford, we’re proud of our diverse talented team and committed to cultivating an environment of inclusion where we strive to instill a strong sense of belonging, and support each Obsidianite to continuously learn and contribute their best work. We offer competitive salary and benefits, and potential for employee ownership through stock options.
-